Anixa Biosciences, Inc. (ANIX) Financials
ANIX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 25.4 million | 1.8 million |
| 2023-10-31 | 25.5 million | 2.2 million |
| 2023-07-31 | 26.6 million | 2.0 million |
| 2023-04-30 | 27.6 million | 1.7 million |
ANIX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | -2.3 million | 1.1 million |
| 2023-10-31 | -2.0 million | 1.2 million |
| 2023-07-31 | -1.4 million | 1.2 million |
| 2023-04-30 | -807000 | 1.2 million |
ANIX Net Income
No data available :(
ANIX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 23.8 million | - | 162000 |
| 2023-10-31 | 23.8 million | - | 175000 |
| 2023-07-31 | 25.5 million | - | 187000 |
| 2023-04-30 | 27.0 million | - | 198000 |
ANIX Shares Outstanding
ANIX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | - | 1.3 million | 2.3 million | - |
| 2023-10-31 | - | 1.6 million | 1.4 million | - |
| 2023-07-31 | - | 1.1 million | 1.8 million | - |
| 2023-04-30 | - | 998000 | 1.6 million | - |
ANIX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | - | - |
| 2023-10-31 | 156000 | 12000 |
| 2023-07-31 | - | 11000 |
| 2023-04-30 | 210000 | 161000 |
ANIX
Price: $2.95
52 week price:
Earnings Per Share: -0.34 USD
P/E Ratio: -14.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 24809
Market Capitalization: 102.7 million